Phase 2 study of cobimetinib in combination with vemurafenib in active melanoma brain metastases (coBRIM-B) Meeting Abstract


Authors: Yee, M. K.; Lin, Y.; Gorantla, V. C.; Butterfield, L. H.; Kluger, H. M.; Chapman, P. B.; Gangadhar, T. C.; Milhem, M. M.; Pavlick, A. C.; Amaravadi, R. K.; Schuchter, L. M.; Tarhini, A. A.; Kirkwood, J. M.; Tawbi, H. A. H.
Abstract Title: Phase 2 study of cobimetinib in combination with vemurafenib in active melanoma brain metastases (coBRIM-B)
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036904886
PROVIDER: wos
Notes: Meeting Abstract: TPS9088 -- Source: Wos
MSK Authors
  1. Paul Chapman
    241 Chapman